Hanfords US Vet Go-Dry Dry Cow Mastitis Treatment (30 lb)

Hanfords US Vet

  • $29.99
    Unit price per 


ToMORROW gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows. 

  • ToMORROW has been an effective prolonged therapy treatment for more than 25 years, and studies have shown no change in the development of bacterial resistance.1,2

  • ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows when caused by  Streptococcus agalactiae  and  Staphylococcus aureus  including penicillin-resistant strains.

  • ToMORROW is formulated with cephapirin benzathine to provide broad spectrum and long-acting therapy that dry cows need.

Features & Benefits

TOP REASONS TO USE ToMORROW® (cephapirin benzathine)

  • Shorter milk withhold.
    72 hours after calving versus 96 hours for QUARTERMASTER means you can put your cows back into production sooner after calving. 

  • Shorter slaughter withhold.
    42 days after last infusion with ToMORROW treatment compared to 60 days for QUARTERMASTER allows you to move 18 days faster. 

  • Targets the bacteria most common at dry-off.
    ToMORROW treatment effectively controls Gram-positive organisms, which represent 94% of infections that occur during dry-off.1 

  • Less expensive, equally effective.
    Producers and vets can save an average of 35% per cow when treating with ToMORROW vs. SPECTRAMAST DC.3 

  • Increases convenience and reduces the risk of new infections.
    The Opti-Sert® tip reduces new mastitis infections by up to 50%4 and makes partial insertion much easier.

Dosage & Administration


  • Pail containing 144 x 10-mL syringes and 144 convenient single-use alcohol pads.

  • Cartons containing 12 x 10-mL syringes with 12 convenient single-use alcohol pads. 

Partial insertion reduces new infections

  • With the Opti-Sert® applicator tip, partial insertion reduces the incidence of new infections during the dry period.4

  • Studies have shown that when infusing into the udder at a depth of 2 to 3 millimeters, as opposed to 5 or more millimeters, new intramammary infections can be reduced by as much as 50 percent.4 

Dosage Information

  • Infuse a 10-mL syringe (300 mg cephapirin activity per syringe) after each quarter has been completely milked out.


We Also Recommend